Department of Physics and Astronomy, University of British Columbia, Vancouver, BC, Canada; International Collaboration on Repair Discoveries, University of British Columbia, Vancouver, BC, Canada.
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Mult Scler Relat Disord. 2022 Jan;57:103366. doi: 10.1016/j.msard.2021.103366. Epub 2021 Nov 3.
Neurofilaments are cytoskeletal proteins that are detectable in the blood after neuroaxonal injury. Multiple sclerosis (MS) disease progression, greater lesion volume, and brain atrophy are associated with higher levels of serum neurofilament light chain (NfL), but few studies have examined the relationship between NfL and advanced magnetic resonance imaging (MRI) measures related to myelin and axons. We assessed the relationship between serum NfL and brain MRI measures in a diverse group of MS participants.
103 participants (20 clinically isolated syndrome, 33 relapsing-remitting, 30 secondary progressive, 20 primary progressive) underwent 3T MRI to obtain myelin water fraction (MWF), geometric mean T (GMT), water content, T high angular resolution diffusion imaging (HARDI)-derived axial diffusivity (AD), radial diffusivity (RD), fractional anisotropy (FA); diffusion basis spectrum imaging (DBSI)-derived AD, RD, FA; restricted, hindered, water and fiber fractions; and volume measurements of normalized brain, lesion, thalamic, deep gray matter (GM), and cortical thickness. Multiple linear regressions assessed the strength of association between serum NfL (dependent variable) and each MRI measure in whole brain (WB), normal appearing white matter (NAWM) and T lesions (independent variables), while controlling for age, expanded disability status scale, and disease duration.
Serum NfL levels were significantly associated with metrics of axonal damage (FA: R = 0.29, R = 0.31, R = 0.30, R = 0.31; AD: R=0.31), myelin damage (MWF: R = 0.29, R = 0.30, RD: R = 0.32, R = 0.34, R = 0.30), edema and inflammation (T: R = 0.32; GMT: R = 0.31, R = 0.31), and cellularity (restricted fraction R = 0.30, R = 0.32) across the entire MS cohort. Higher serum NfL levels were associated with significantly higher T lesion volume (R = 0.35), lower brain structure volumes (thalamus R = 0.31; deep GM R = 0.33; normalized brain R = 0.31), and smaller cortical thickness R = 0.31).
The association between NfL and myelin MRI markers suggest that elevated serum NfL is a useful biomarker that reflects not only acute axonal damage, but also damage to myelin and inflammation, likely due to the known synergistic myelin-axon coupling relationship.
神经丝是细胞骨架蛋白,在神经轴突损伤后可在血液中检测到。多发性硬化症(MS)疾病进展、更大的病变体积和脑萎缩与更高水平的血清神经丝轻链(NfL)相关,但很少有研究检查 NfL 与与髓鞘和轴突相关的高级磁共振成像(MRI)测量值之间的关系。我们评估了血清 NfL 与 MS 参与者中不同组的脑 MRI 测量值之间的关系。
103 名参与者(20 名临床孤立综合征、33 名复发缓解型、30 名继发进展型、20 名原发进展型)接受了 3T MRI 以获得髓鞘水分数(MWF)、几何平均值 T(GMT)、水含量、高角分辨率扩散成像(HARDI)衍生的轴向扩散率(AD)、径向扩散率(RD)、各向异性分数(FA);扩散基础谱成像(DBSI)衍生的 AD、RD、FA;受限、受阻、水和纤维分数;以及正常化脑、病变、丘脑、深部灰质(GM)和皮质厚度的体积测量值。多元线性回归评估了血清 NfL(因变量)与全脑(WB)、正常表现白质(NAWM)和 T 病变(自变量)之间的关联强度,同时控制年龄、扩展残疾状况量表和疾病持续时间。
血清 NfL 水平与轴突损伤指标(FA:R=0.29、R=0.31、R=0.30、R=0.31;AD:R=0.31)、髓鞘损伤指标(MWF:R=0.29、R=0.30、RD:R=0.32、R=0.34、R=0.30)、水肿和炎症指标(T:R=0.32;GMT:R=0.31、R=0.31)和细胞指标(受限分数 R=0.30、R=0.32)显著相关。在整个 MS 队列中。较高的血清 NfL 水平与 T 病变体积显著增加(R=0.35)、脑结构体积减小(丘脑 R=0.31;深部 GM R=0.33;正常化脑 R=0.31)和皮质厚度减小(R=0.31)相关。
NfL 与髓鞘 MRI 标志物之间的关联表明,升高的血清 NfL 是一种有用的生物标志物,不仅反映了急性轴突损伤,还反映了髓鞘和炎症损伤,这可能是由于已知的髓鞘-轴突协同耦合关系。